Antiphospholipid Antibody Associated Young Stroke

Introduction: Overview of stroke in young adults and the role of antiphospholipid antibodies as a rare but significant cause.

Epidemiology: Prevalence of antiphospholipid syndrome (APS) among young stroke patients.

Pathophysiology: Mechanism of hypercoagulability leading to arterial thrombosis in APS.

Risk Factors: Contributing factors such as autoimmune disorders, smoking, and hormonal therapy.

Clinical Presentation: Typical neurological deficits and patterns of stroke in APS.

Diagnostic Evaluation: Role of imaging and laboratory tests including lupus anticoagulant and anticardiolipin antibodies.

Management: Acute stroke treatment and long-term anticoagulation strategies.

Prognosis and Complications: Risk of recurrence and long-term neurological outcomes.

Conclusion: Importance of early recognition and targeted therapy to prevent recurrent strokes.